/Investor DB

Alix Ventures — Full Portfolio

20 tracked investments · listed companies and verified rows first

64x Bio64xbio.comin𝕏Series A · Jan 2022 · $55M

64x Bio develops cell-line engineering and production technologies to overcome manufacturing bottlenecks in advanced and next-generation therapies.

AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesSan Francisco, US

Lexi Rovner(CEO, Co-founder, Board of Directors)inAlexis Rovner(Founder)Ryan GallagherEmily Hawkins(Head of Talent)George Church, PhD(Co-founder, Scientific Advisory Board)David Thompson, PhD(Co-founder, Scientific Advisory Board)

Co-investorsFifty YearsFuture VenturesG VenturesLifeforce CapitalRaptor GroupY Combinator+8 more

Basil Systemsbasilsystems.comin

Basil Systems provides a big-data SaaS platform called Basil Intel that consolidates global regulatory, clinical, safety, and commercial data into a single indexed dataset for analytics and insights.

AI & Machine LearningHealthtechSaaSBoston, US

Anthony Cirurgiao(Executive Officer, Director)Luca Fabbri(Director)Bert Amato(Director)

Co-investorsAlumni VenturesService Provider CapitalUntapped CapitalWild Basin InvestmentsGolden VenturesHearst Ventures+1 more

Chemifychemify.ioin

Chemify builds automated chemical synthesis systems combining chemistry, AI, and robotics to digitize molecular design and manufacturing.

AI & Machine LearningBiotechDeep TechGlasgow, GB

Lee Cronin(Founder)inLeroy Cronin(Founder)

Co-investorsBlueYard CapitalInsight PartnersCreator FundEos AdvisoryHAWKTAILHorizons Ventures+12 more

Elegenelegenbio.comin𝕏Jun 2024 · $35M

Elegant Bio develops DNA synthesis technology and services, offering ENFINIA™ DNA synthesis at scale for biotech and research applications.

BiotechDeep TechSan Carlos, US

Matthew Hill(Executive Officer, Director)in

BoardPeter Zhou(Director)inCain McClary(Director)inJonathan Sheena(Director)in

Co-investorsACVC PartnersAndreessen HorowitzIn-Q-TelKdT VenturesRaptor GroupTriatomic Capital+3 more

Endpoint Healthendpointhealth.comin𝕏Series ADefunct

Endpoint Health develops and commercializes precision therapeutics and therapy-guiding diagnostic tests targeted to each patient's biology, focused on immune-driven critical and chronic illnesses.

BiotechDigital HealthHealthtechSan Francisco, US

Diego Rey(Founder/CSO)inJeff Osborn(Founder)inJason Springs(Founder)inLeonardo Teixeira(Founder)in

Co-investorsGlobal Health Investment CorporationKnockout CapitalY CombinatorAME Cloud VenturesBoom CapitalBoom Capital Ventures+6 more

iOrganBioiorgan.bioOct 2025

iOrganBio builds CellForge, an AI- and automation-driven platform for engineering and manufacturing human cells and organoids.

Co-investorsCape Fear BioCapitalFirst Star VenturesHartmann CapitalSOSVIndieBio

Mythic AImythic.aiin𝕏

Mythic builds analog processing units based on compute-in-memory architecture designed to run AI workloads efficiently in real-world applications.

AI & Machine LearningHardwareSemiconductorsPalo Alto, US

Mike Henry(Founder)inTaner Ozcelik(CEO / Board Member)inSteven Pho(CFO)Dave Fick(Founder)

Co-investorsCatapult VenturesLinse CapitalNew Enterprise Associates (NEA)S3 VenturesAtreides ManagementDCVC (Data Collective)+17 more

Pair Teampairteam.comin𝕏Seed

Pair Team operates a medical group and is building an AI-based care manager for complex, low-income patients covered by Medicaid, Medicare, and public assistance programs, addressing clinical, behavioral, and social needs such as housing, food, and transportation.

AI & Machine LearningDigital HealthHealthtechSan Francisco, US

Neil Batlivala(Founder)inCassie Choi(Founder)inCassandra Choi(Executive Officer, Director)inAndres Calabrese(Engineer)Lucas Cook(Software Engineer)Lori Sparks(Recruiting)

Co-investorsAugment VenturesCraft VenturesCREATE HEALTH VENTURESGaingelsHead & Heart CapitalHeadwater Ventures+18 more

Strandtxstrandtx.comin𝕏

Strand is a clinical-stage biotechnology company developing programmable mRNA therapeutics for cancers and autoimmune diseases.

AI & Machine LearningBiotechMedical DevicesBoston, US

Jacob Becraft(CEO, Co-Founder)inTasuku Kitada(President, Head of R&D, Co-founder)inRon Weiss(Scientific Co-founder)inDarrell J. Irvine(Scientific Co-founder)inPrashant Nambiar(Chief Scientific Officer)Ethan Cash(Senior Vice President, Head of Portfolio Management and Program Development)in

Co-investorsAtinum Investment Co. Ltd.FPVLG Technology VenturesPlayground GlobalPotentum PartnersAmgen Ventures+5 more

Teiko Bioteiko.bioin𝕏Sep 2021

Teiko provides CLIA-validated high-dimensional cytometry services—including spectral flow and mass cytometry panels, blood preservation kits, gating, and a data analysis dashboard—for immune cell profiling in clinical trials.

BiotechDigital HealthHealthtechSalt Lake City, US

Ramji Srinivasan(Executive Officer, Director)inMatt(Co-founder)inMatthew Spitzer(Director)

BoardVictor Wang(Director)in

Co-investorsCivilization Ventures Management, LlcHAWKTAILHOF CapitalTau VenturesTwine VenturesWestern Technology Investment+2 more

Zafrenszafrens.cominDec 2021

Zafrens develops a unified drug discovery platform that integrates isolation, imaging, and sequencing workflows to accelerate the identification of therapeutic compounds across modalities.

AI & Machine LearningBiotechDeep TechSan Diego, US

Martin SmrcinainMaina NdunguinSwamy Vijayan(Executive Officer, Director)inYi ZhanginVikas Goelin

BoardJustin Briggsin

Co-investorsAcequia Capital (AceCap)BlueYard CapitalFoundersX VenturesGlobal BrainHAWKTAILIaso Ventures+3 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

64xCircularisCloraCytosolixExthymicGalateaSTRMXilis, Inc.

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.